Status:
UNKNOWN
Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina
Lead Sponsor:
Cardium Therapeutics
Conditions:
Stable Angina
Eligibility:
All Genders
30-75 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine whether a single intracoronary infusion of Ad5FGF-4 is effective in improving exercise capacity measured by exercise treadmill testing, angina functional clas...
Eligibility Criteria
Inclusion
- CCS class II - IV, technically unsuitable for revascularization by CABG or PTCA able to exercise between 3 and 10 minutes on treadmill
Exclusion
- Unstable angina, CCS class 1 angina optimal candidates for revascularization
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT00185263
Start Date
March 1 2002
End Date
November 1 2008
Last Update
November 6 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.